Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Ainos, Inc. (AIMD)

    Price:

    2.23 USD

    ( + 0.03 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    AIMD
    Name
    Ainos, Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    2.230
    Market Cap
    10.732M
    Enterprise value
    29.775M
    Currency
    USD
    Ceo
    Chun-Hsien Tsai
    Full Time Employees
    44
    Website
    Ipo Date
    2021-01-08
    City
    San Diego
    Address
    8880 Rio San Diego Drive

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Regeneron Pharmaceuticals, Inc.

    VALUE SCORE:

    6

    Symbol
    REGN
    Market Cap
    76.562B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    4.706B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Genmab A/S

    VALUE SCORE:

    11

    Symbol
    GMAB
    Market Cap
    122.616B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.679
    P/S
    94.944
    P/B
    1.011
    Debt/Equity
    1.095
    EV/FCF
    -4.421
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    182.276
    Earnings yield
    -1.473
    Debt/assets
    0.485
    FUNDAMENTALS
    Net debt/ebidta
    -0.922
    Interest coverage
    -39.123
    Research And Developement To Revenue
    70.373
    Intangile to total assets
    0.898
    Capex to operating cash flow
    -0.008
    Capex to revenue
    0.327
    Capex to depreciation
    0.008
    Return on tangible assets
    -6.465
    Debt to market cap
    1.025
    Piotroski Score
    5.000
    FUNDAMENTALS
    PEG
    4.577
    P/CF
    -2.196
    P/FCF
    -2.303
    RoA %
    -65.949
    RoIC %
    -64.834
    Gross Profit Margin %
    82.689
    Quick Ratio
    2.673
    Current Ratio
    2.960
    Net Profit Margin %
    -13.232k
    Net-Net
    -2.508
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.023
    Revenue per share
    0.025
    Net income per share
    -3.284
    Operating cash flow per share
    -1.015
    Free cash flow per share
    -1.023
    Cash per share
    0.248
    Book value per share
    2.206
    Tangible book value per share
    -2.266
    Shareholders equity per share
    2.206
    Interest debt per share
    2.496
    TECHNICAL
    52 weeks high
    5.000
    52 weeks low
    1.780
    Current trading session High
    2.290
    Current trading session Low
    2.160
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    -6.414769%
    P/E
    -0.002
    logo

    Country
    KY
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.285
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.410
    logo

    Country
    IL
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.671
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.797
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.117
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.300
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.628
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.177
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.570
    DESCRIPTION

    Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

    NEWS
    https://images.financialmodelingprep.com/news/ainos-otcmktsaimd-stock-price-down-1-time-to-sell-20251202.jpg
    Ainos (OTCMKTS:AIMD) Stock Price Down 1% – Time to Sell?

    defenseworld.net

    2025-12-02 02:26:49

    Ainos, Inc. (OTCMKTS:AIMD - Get Free Report) traded down 1% on Monday. The company traded as low as $2.02 and last traded at $2.08. 6,450 shares were traded during trading, a decline of 99% from the average session volume of 703,132 shares. The stock had previously closed at $2.10. Ainos Stock Performance The company

    https://images.financialmodelingprep.com/news/ainos-nasdaqaimd-stock-price-up-05-whats-next-20251122.jpg
    Ainos (NASDAQ:AIMD) Stock Price Up 0.5% – What’s Next?

    defenseworld.net

    2025-11-22 02:34:55

    Ainos, Inc. (NASDAQ: AIMD - Get Free Report) traded up 0.5% during trading on Friday. The company traded as high as $1.99 and last traded at $1.92. 20,799 shares changed hands during trading, a decline of 97% from the average session volume of 718,317 shares. The stock had previously closed at $1.91. Wall Street Analyst

    https://images.financialmodelingprep.com/news/ainos-reports-third-quarter-2025-financial-results-20251113.jpg
    Ainos Reports Third Quarter 2025 Financial Results

    accessnewswire.com

    2025-11-13 16:15:00

    Digital olfactory commercialization accelerates toward 2026 scale-up, as industrial partnerships expand to six and the IP moat strengthens. World's first patented commercial AI Nose device launched, advancing SmellTech-as-a-Service adoption.

    https://images.financialmodelingprep.com/news/ainos-inc-nasdaqaimd-short-interest-update-20251031.jpg
    Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

    defenseworld.net

    2025-10-31 01:48:46

    Ainos, Inc. (NASDAQ: AIMD - Get Free Report) saw a large decrease in short interest in October. As of October 15th, there was short interest totaling 12,400 shares, a decrease of 46.6% from the September 30th total of 23,200 shares. Based on an average daily volume of 2,260,000 shares, the short-interest ratio is presently 0.0 days.

    https://images.financialmodelingprep.com/news/water-tower-research-spotlights-ainosnexcom-partnership-as-catalyst-for-20251020.jpg
    Water Tower Research Spotlights Ainos-NEXCOM Partnership as Catalyst for High-Growth Edge AI Expansion

    accessnewswire.com

    2025-10-20 08:30:00

    Collaboration brings AI Nose to the edge, advancing intelligent sensing and industrial sustainability Partnership taps ~$60 billion edge AI market, expanding global industrial channels and accelerating AI Nose commercialization SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 20, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research ("WTR") has published a report highlighting Ainos' strategic partnership with NEXCOM International Co., Ltd. ("NEXCOM"), a Taiwan-based pioneer in industrial computing and edge AI solutions.

    https://images.financialmodelingprep.com/news/ainos-and-nexcom-partner-to-expand-ai-nose-ecosystem-20251014.jpg
    Ainos and NEXCOM Partner to Expand AI Nose Ecosystem into Industrial Edge AI

    accessnewswire.com

    2025-10-14 08:30:00

    Collaboration Combines SmellTech and Edge AI for Intelligent Environmental Sensing Partnership Expands AI Nose's Industrial Ecosystem and Commercial Reach SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a leader in AI-powered scent digitization, today announced a strategic partnership with NEXCOM International Co., Ltd., a leader in industrial computing and edge AI solutions, to advance the integration of Ainos' AI Nose technology into NEXCOM's industrial edge computing platforms.

    https://images.financialmodelingprep.com/news/water-tower-research-highlights-ainos-transition-to-technology-company-20251007.jpg
    Water Tower Research Highlights Ainos' Transition to Technology Company Following GICS Reclassification

    accessnewswire.com

    2025-10-07 08:30:00

    New GICS code increases visibility among technology investors as Ainos builds commercial momentum around its AI-powered digital olfaction platform Expanded partnerships and IP portfolio to strengthen Ainos' SmellTech-as-a-Service model and competitive edge SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 7, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research (WTR) issued a new report spotlighting Ainos' formal reclassification under the Global Industry Classification Standard (GICS®) to the technology sector from biotechnology, effective October 1, 2025. The report recognizes Ainos' transformation into a technology-driven company built around its proprietary AI-powered digital olfaction platform, AI Nose.

    https://images.financialmodelingprep.com/news/ainos-announces-gics-reclassification-to-information-technology-sector-20251002.jpg
    Ainos Announces GICS Reclassification to Information Technology Sector

    accessnewswire.com

    2025-10-02 08:30:00

    Five strategic industrial partnerships accelerate AI Nose adoption across semiconductors, robotics, smart manufacturing, and healthcare SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 2, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced its reclassification under the Global Industry Classification Standard (GICS®) to Technology Hardware, Storage & Peripherals (Code 45202030), effective October 1, 2025. The update, administered by S&P Dow Jones Indices and MSCI, marks Ainos' transition from biotechnology to the emerging field of digital olfaction-positioning the Company as a technology innovator enabling artificial intelligence to sense smell.

    https://images.financialmodelingprep.com/news/ainos-expands-global-ip-portfolio-to-123-patents-with-20250930.jpg
    Ainos Expands Global IP Portfolio to 123 Patents with Seven New AI Nose Patents

    accessnewswire.com

    2025-09-30 08:30:00

    New Patents in Europe, Germany, Taiwan, and China Strengthen SmellTech Leadership Expanding IP Moat to Accelerate Commercialization of AI Nose Across Healthcare, Semiconductors, and Robotics SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured seven new patents in Europe, Germany, Taiwan and China that strengthen its AI Nose digital olfaction platform and its applications in robotics. With these additions, Ainos now holds 123 active patents across key technologies, covering the U.S., Europe, Germany, Japan, Taiwan, and China.

    https://images.financialmodelingprep.com/news/water-tower-research-highlights-ainostopco-alliance-as-catalyst-for-20250918.jpg
    Water Tower Research Highlights Ainos-Topco Alliance as Catalyst for AI Nose Global Commercialization

    accessnewswire.com

    2025-09-18 08:30:00

    Fifth strategic industrial collaboration in 2025 strengthens Ainos' cross-industry ecosystem Topco partnership expands AI Nose's global reach across key industries, accelerating its path toward large-scale commercialization in 2026 SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 18, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has published a report spotlighting Ainos' distribution partnership with leading global semiconductor solutions provider Topco Scientific Co., Ltd. (TWSE: 5434, "Topco"), a milestone that propels the Company toward large-scale commercialization of its AI Nose platform in 2026.

    https://images.financialmodelingprep.com/news/ainos-and-topco-sign-distribution-agreement-to-accelerate-global-20250916.png
    Ainos and Topco Sign Distribution Agreement to Accelerate Global Expansion of AI Nose

    accessnewswire.com

    2025-09-16 09:30:00

    Partnership to accelerate commercialization of Ainos' AI Nose across semiconductors, healthcare, and smart manufacturing Topco brings 35 years of trusted global supply chain ties and customer access SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 16, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"), a pioneer in AI-powered scent digitization, today announced it has signed a distribution agreement with Topco Scientific Co., Ltd. (TWSE: 5434, "Topco"), one of Taiwan's leading semiconductor solution providers.

    https://images.financialmodelingprep.com/news/water-tower-research-fireside-chat-with-ainos-ai-nose-20250826.jpg
    Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up

    accessnewswire.com

    2025-08-26 09:30:00

    From biotech to SmellTech, Ainos transforms as a first mover in next-gen sensory AI Proprietary smell language model and scent data create unique competitive moat SmellTech flywheel spins toward 2026 scale-up, turning data into recurring revenue SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has published a report spotlighting AI Nose's first-mover breakthrough in giving AI the sense of smell, along with the Company's commercialization roadmap and pathway to profitability. The report draws insights from a management fireside chat on August 20, 2025.

    https://images.financialmodelingprep.com/news/water-tower-research-initiates-technology-coverage-of-ainos-highlighting-20250819.jpg
    Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation

    accessnewswire.com

    2025-08-19 09:30:00

    Early revenues and $2.1M SmellTech-as-a-Service order set the stage for large-scale commercialization in 2026 Robotics and industrial deployments expand long-term growth runway beyond healthcare SAN DIEGO, CA / ACCESS Newswire / August 19, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has assumed coverage of Ainos under its Technology research platform, transitioning from its prior coverage under the Emerging Growth category. This move underscores Ainos' strategic transformation from biotech roots to a multi-sector AI technology innovator, with its proprietary AI Nose platform poised to ignite the Company's next phase of growth across healthcare, robotics, and industrial applications.

    https://images.financialmodelingprep.com/news/ainos-debuts-worlds-first-patented-ai-nose-device-bringing-20250814.jpg
    Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare

    accessnewswire.com

    2025-08-14 09:30:00

    Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments Underway SmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead in Scent Intelligence. Debuting at Automation Taipei 2025 in Partnership with Kenmec and ugo SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today launched its first commercial AI Nose module optimized for industrial and healthcare settings, marking a pivotal milestone in the global commercialization of AI-powered digital olfaction.

    https://images.financialmodelingprep.com/news/ainos-reports-second-quarter-2025-financial-results-20250813.jpg
    Ainos Reports Second Quarter 2025 Financial Results

    accessnewswire.com

    2025-08-13 16:15:00

    1H 2025 Kicks Off AI Nose's Growing Commercial Momentum with First Senior Care Revenue and New Strategic Partnerships AI Nose 90-Day Roadmap to Power 2H 2025, with First Multi-Year $2.1M Order and Traction Across Robotics, Semiconductors, and Smart Manufacturing SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-driven scent digitization, today announced its financial results for the second quarter ended June 30, 2025. Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "We're thrilled that our proprietary AI-powered scent digitization platform, AI Nose, has entered the commercial execution phase.